GE Healthcare To Pay Up For Export Violations

Law360, New York (May 7, 2010, 6:03 PM EDT) -- GE Healthcare Bioscience BioProcess Corp. has agreed to pay $126,000 to resolve allegations that it exported and re-exported bioreactor kits to China, Mexico and elsewhere without obtaining the proper licenses from the U.S. Department of Commerce.

The alleged violations were committed by Wave Biotech LLC, a company acquired by GE Healthcare in April 2007, according to a settlement agreement posted on Commerce's Bureau of Industry and Security Web site Friday.

Wave unlawfully exported the bioreactor kits from the U.S. to Mexico, Singapore, Taiwan, India and China...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.